首页 | 本学科首页   官方微博 | 高级检索  
     


Setting up a fertility preservation programme
Affiliation:1. Melbourne IVF, 344 Victoria Parade, East Melbourne, Victoria 3002, Australia;2. The Royal Women''s Hospital, Reproductive Services Unit, 20 Flemington Road, Parkville, Victoria 3052, Australia;1. Centre for Health Services Research, Faculty of Medicine, The University of Queensland, Level 2, Building 33, Princess Alexandra Hospital, Woolloongabba, QLD 4102, Brisbane, Australia;2. Queensland Centre for Gynaecological Cancer, Royal Brisbane & Women''s Hospital, 6th Floor Ned Hanlon Building, Herston QLD 4029, Brisbane, Australia;3. Clinical School, Faculty of Medicine, The University of Queensland, Herston QLD 4029, Brisbane, Australia;1. Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA;2. Department of Gynecology and Obstetrics, Faculty of Medicine and Biomedical Sciences, University of Yaoundé I, Cameroon;1. Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia;2. Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Parkville, Victoria, Australia;3. Sir Peter MacCallum Dept of Oncology, The University of Melbourne, Parkville, Victoria, Australia;1. Department of Urology, University of North Carolina, 2113 Physician’s Office Building, CB#7235, Chapel Hill, NC 27599-7235, USA;2. UNC Fertility, 7920 ACC Blvd #300, Raleigh, North Carolina 27617, USA;1. Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology and Infertility, Washington University School of Medicine in St. Louis, St. Louis, MO, United States;2. Washington University, 660 Euclid Avenue, St. Louis, MO, United States;3. Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States;4. Division of Reproductive Endocrinology, Department of Gynecology and Obstetrics, Emory University School of Medicine, Atlanta, GA, United States;5. Department of Obstetrics and Gynecology, Northwestern University Feinberg School of Medicine, Chicago, IL, United States;1. Reproductive Services, Royal Women''s Hospital/ Melbourne IVF, Victoria, Australia;2. Department of Obstetrics and Gynaecology, University of Melbourne, Victoria, Australia
Abstract:With improved survival rates from cancer, young people can expect to lead a normal life, including having their own children. However, cancer or other serious disease itself, and more often its treatment, often leads to a significant reduction in fertility or premature gonadal insufficiency. There is increasing acknowledgement for the importance of fertility preservation (FP) options to be discussed and offered to young people whose fertility is at risk, ideally before the gonadotoxic therapy begins. FP options currently include oocyte, embryo and ovarian tissue cryopreservation; ovarian protection during chemotherapy and semen, sperm and testicular tissue cryopreservation. A multidisciplinary team consisting of committed and enthusiastic doctors, scientists, nurses, counsellors, administrators and researchers is required to provide a holistic FP service with rapid response capacity for acute consultation and procedures and a robust system for long-term follow-up. This speciality is developing rapidly with exciting scientific advances that have relevance for the whole spectrum of reproductive medicine.
Keywords:Fertility preservation  Gonadal insufficiency  Cancer
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号